Home/Filings/4/0001209191-24-004208
4//SEC Filing

Oakes Gregory 4

Accession 0001209191-24-004208

CIK 0001785345other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 4:06 PM ET

Size

5.8 KB

Accession

0001209191-24-004208

Insider Transaction Report

Form 4
Period: 2024-02-29
Oakes Gregory
DirectorChief Executive Officer
Transactions
  • Award

    Restricted Stock Unit

    2024-02-29+54,45454,454 total
    Exp: 2034-02-28Common Stock (54,454 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents the right to receive one share of Landos Biopharma, Inc., Inc. common stock.
  • [F2]The Restricted Stock Unit ("RSU") shall vest as to 66 2/3% of the shares underlying the RSU on the second anniversary of the date of grant and shall vest as to 33 1/3% of the shares underlying the RSU on the third anniversary of the date of grant, subject to the Reporting Person's continuous service with the Issuer on each such date.

Issuer

Landos Biopharma, Inc.

CIK 0001785345

Entity typeother

Related Parties

1
  • filerCIK 0001809796

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:06 PM ET
Size
5.8 KB